The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China
Open accessAbstract
Importance: In China, diabetes prevalence has increased substantially in recent decades, but there are no reliable estimates of the excess mortality currently associated with diabetes. Objectives: To assess the proportional excess mortality associated with diabetes and estimate the diabetes-related absolute excess mortality in rural and urban areas of China. Design, Setting, and Participants: A 7-year nationwide prospective study of 512 869 adults aged 30 to 79 years from 10 (5 rural and 5 urban) regions in China, who were recruited between June 2004 and July 2008 and were followed up until January 2014. Exposures: Diabetes (previously diagnosed or detected by screening) recorded at baseline. Main Outcomes and Measures: All-cause and cause-specific mortality, collected through established death registries. Cox regression was used to estimate adjusted mortality rate ratio (RR) comparing individuals with diabetes vs those without diabetes at baseline. Results: Among the 512 869 participants, the mean (SD) age was 51.5 (10.7) years, 59% (n = 302 618) were women, and 5.9% (n = 30 280) had diabetes (4.1% in rural areas, 8.1% in urban areas, 5.8% of men, 6.1% of women, 3.1% had been previously diagnosed, and 2.8% were detected by screening). During 3.64 million person-years of follow-up, there were 24 909 deaths, including 3384 among individuals with diabetes. Compared with adults without diabetes, individuals with diabetes had a significantly increased risk of all-cause mortality (1373 vs 646 deaths per 100 000; adjusted RR, 2.00 [95% CI, 1.93-2.08]), which was higher in rural areas than in urban areas (rural RR, 2.17 [95% CI, 2.07-2.29]; urban RR, 1.83 [95% CI, 1.73-1.94]). Presence of diabetes was associated with increased mortality from ischemic heart disease (3287 deaths; RR, 2.40 [95% CI, 2.19-2.63]), stroke (4444 deaths; RR, 1.98 [95% CI, 1.81-2.17]), chronic liver disease (481 deaths; RR, 2.32 [95% CI, 1.76-3.06]), infections (425 deaths; RR, 2.29 [95% CI, 1.76-2.99]), and cancer of the liver (1325 deaths; RR, 1.54 [95% CI, 1.28-1.86]), pancreas (357 deaths; RR, 1.84 [95% CI, 1.35-2.51]), female breast (217 deaths; RR, 1.84 [95% CI, 1.24-2.74]), and female reproductive system (210 deaths; RR, 1.81 [95% CI, 1.20-2.74]). For chronic kidney disease (365 deaths), the RR was higher in rural areas (18.69 [95% CI, 14.22-24.57]) than in urban areas (6.83 [95% CI, 4.73-9.88]). Among those with diabetes, 10% of all deaths (16% rural; 4% urban) were due to definite or probable diabetic ketoacidosis or coma (408 deaths). Conclusions and Relevance: Among adults in China, diabetes was associated with increased mortality from a range of cardiovascular and noncardiovascular diseases. Although diabetes was more common in urban areas, it was associated with greater excess mortality in rural areas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Prevalence of Diabetes among Men and Women in China
Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908292 · Cited by 3,031
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726 · cited 4×
“In many Western populations, diabetes is associatedwithmore deaths from IHD than fromstroke,whereas in China the opposite is true, even though themortality RRs for IHD and stroke in the present study were similar to those reportedpreviously.(7-9)Moreover,existingevidencerelatinghemorrhagic stroke to diabetes ismore li…”
BackgroundResultInfluentialPrevalence and Control of Diabetes in Chinese Adults
Xu, Y. (2013) · JAMA · doi:10.1001/jama.2013.168118 · Cited by 2,703
Prevalence of chronic kidney disease in China: a cross-sectional survey
Zhang, L., Wang, F., Wang, L., Wang, W., Liu, B., Liu, J., Chen, M., He, Q., Liao, Y., Yu, X., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60033-6 · Cited by 2,091
Self-citationRapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
Yang, G., Wang, Y., Zeng, Y., Gao, G. F., Liang, X., Zhou, M., Wan, X., Yu, S., Jiang, Y., Naghavi, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61097-1 · Cited by 1,982
Use and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
Zhou, M., Wang, H., Zhu, J., Chen, W., Wang, L., Liu, S., Li, Y., Wang, L., Liu, Y., Yin, P., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00551-6 · Cited by 1,464
Self-citationChen, Z., Chen, J., Collins, R., Guo, Y., Peto, R., Wu, F., Li, L., & on behalf of the China Kadoorie Biobank (CKB) collaborative group (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr120 · Cited by 1,034 · cited 1×
“Methods Details of the China Kadoorie Biobank (CKB) design, its methods, and its participants have been reported previously.(14,15) Briefly, the 2004-2008 baseline survey took place in 10 (5 urban and 5 rural) localities across China, chosen from China’s nationally representative Disease Surveillance Points system to…”
MethodSelf-citationExcess Mortality among Persons with Type 2 Diabetes
Tancredi, M., Rosengren, A., Svensson, A.-M., Kosiborod, M., Pivodic, A., Gudbjörnsdottir, S., Wedel, H., Clements, M., Dahlqvist, S., & Lind, M. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504347 · Cited by 996
Cited by
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013
Wang, L., Gao, P., Zhang, M., Huang, Z., Zhang, D., Deng, Q., Li, Y., Zhao, Z., Qin, X., Jin, D., et al. (2017) · JAMA · doi:10.1001/jama.2017.7596 · Cited by 1,844
Lin, X., Xu, Y., Pan, X., Xu, J., Ding, Y., Sun, X., Song, X., Ren, Y., & Shan, P.-F. (2020) · Scientific Reports · doi:10.1038/s41598-020-71908-9 · Cited by 1,819
Prevalence and Treatment of Diabetes in China, 2013-2018
Wang, L., Peng, W., Zhao, Z., Zhang, M., Shi, Z., Song, Z., Zhang, X., Li, C., Huang, Z., Sun, X., et al. (2021) · JAMA · doi:10.1001/jama.2021.22208 · Cited by 961
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
China stroke surveillance report 2021
Tu, W.-J., Wang, L.-D., on behalf of the Special Writing Group of China Stroke Surveillance Report, Yan, F., Peng, B., Hua, Y., Liu, M., Ji, X.-M., Ma, L., Shan, C.-L., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00463-x · Cited by 570
Self-citationGlobal liver disease burdens and research trends: Analysis from a Chinese perspective
Xiao, J., Wang, F., Wong, N.-K., He, J., Zhang, R., Sun, R., Xu, Y., Liu, Y., Li, W., Koike, K., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.004 · Cited by 547
Self-citationEpidemiology of diabetes and diabetic complications in China
Ma, R. C. W. (2018) · Diabetologia · doi:10.1007/s00125-018-4557-7 · Cited by 491
Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants
Millett, E. R. C., Peters, S. A. E., & Woodward, M. (2018) · BMJ · doi:10.1136/bmj.k4247 · Cited by 364
Song, P., Yu, J., Chan, K. Y., Theodoratou, E., & Rudan, I. (2018) · Journal of Global Health · doi:10.7189/jogh.08.010803 · Cited by 341
Wang, S., Ma, P., Zhang, S., Song, S., Wang, Z., Ma, Y., Xu, J., Wu, F., Duan, L., Yin, Z., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05209-1 · Cited by 325
Yun, J.-S., & Ko, S.-H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154838 · Cited by 292
Association of Solid Fuel Use With Risk of Cardiovascular and All-Cause Mortality in Rural China
Yu, K., Qiu, G., Chan, K.-H., Lam, K.-B. H., Kurmi, O. P., Bennett, D. A., Yu, C., Pan, A., Lv, J., Guo, Y., et al. (2018) · JAMA · doi:10.1001/jama.2018.2151 · Cited by 287
Self-citationWu, Y., Yao, X., Vespasiani, G., Nicolucci, A., Dong, Y., Kwong, J., Li, L., Sun, X., Tian, H., & Li, S. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.6522 · Cited by 283
Self-citationZhang, Y., Liu, C., Luo, S., Xie, Y., Liu, F., Li, X., & Zhou, Z. (2019) · Journal of Medical Internet Research · doi:10.2196/15023 · Cited by 207
Cao, C., Yang, S., & Zhou, Z. (2020) · Endocrine · doi:10.1007/s12020-020-02223-6 · Cited by 124
Singh, A. K., & Singh, R. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.02.012 · Cited by 114
Lin, S., Ma, Y., Xu, Y., Lu, L., He, J., Zhu, J., Peng, Y., Yu, T., Congdon, N., & Zou, H. (2023) · JMIR Public Health and Surveillance · doi:10.2196/41624 · Cited by 52
Wang, X., Luo, J.-F., Qi, L., Long, Q., Guo, J., & Wang, H.-H. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s211668 · Cited by 37
Hao, J., Luo, S., & Pan, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-14143-8 · Cited by 35
Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists
Piccini, S., Favacchio, G., Morenghi, E., Mazziotti, G., A. Lania, A. G., & Mirani, M. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111689 · Cited by 15
(2024) · doi:10.1186/s12933-024-02246-7 · Cited by 5
Metadata
- Authors
- Bragg, F., Holmes, M. V., Iona, A., Guo, Y., Du, H., Chen, Y., Bian, Z., Yang, L., Herrington, W., Bennett, D., Turnbull, I., Liu, Y., Feng, S., Chen, J., Clarke, R., Collins, R., Peto, R., Li, L., Chen, Z., & for the China Kadoorie Biobank Collaborative Group
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2017-01-17
- Volume
- 317
- Issue
- 3
- Pages
- 280
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2580216878
- Cited by
- 497
- References
- 29
- FWCI
- 30.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.